Antibody Drug Conjugate Therapeutics Market - Global Outlook and Forecast 2021-2027

April 2021 | 106 pages | ID: AEC2195A4CE1EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Antibody Drug Conjugate Therapeutics in Global, including the following market information:

Global Antibody Drug Conjugate Therapeutics Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Antibody Drug Conjugate Therapeutics market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antibody Drug Conjugate Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Antibody Drug Conjugate Therapeutics Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Antibody Drug Conjugate Therapeutics Market Segment Percentages, By Type, 2020 (%)

• Mmunomedics Technology
• Immunogen Technology
• Seattle Genetics Technology
• Others

China Antibody Drug Conjugate Therapeutics Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Antibody Drug Conjugate Therapeutics Market Segment Percentages, By Application, 2020 (%)

• Lymphoma
• Leukemia
• Multiple Myeloma
• Skin Cancer
• Colon Cancer
• Glioblastoma
• Pancreatic Cancer
• Prostate Cancer
• Solid Tumor
• Breast Cancer

Global Antibody Drug Conjugate Therapeutics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Antibody Drug Conjugate Therapeutics Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Antibody Drug Conjugate Therapeutics Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Antibody Drug Conjugate Therapeutics Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Bayer AG
• Pfizer
• Hoffman-Le Roche
• Seattle Genetics
• ImmunoGen
• Genentech
• Synthon Holding
• Sanofi
• Genmab
• Amgen
• Novartis
• Eli Lilly

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Antibody Drug Conjugate Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Antibody Drug Conjugate Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTIBODY DRUG CONJUGATE THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Antibody Drug Conjugate Therapeutics Market Size: 2021 VS 2027
2.2 Global Antibody Drug Conjugate Therapeutics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Antibody Drug Conjugate Therapeutics Players in Global Market
3.2 Top Global Antibody Drug Conjugate Therapeutics Companies Ranked by Revenue
3.3 Global Antibody Drug Conjugate Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Antibody Drug Conjugate Therapeutics Companies in Global Market, by Revenue in 2020
3.5 Global Companies Antibody Drug Conjugate Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antibody Drug Conjugate Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Antibody Drug Conjugate Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Antibody Drug Conjugate Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Antibody Drug Conjugate Therapeutics Market Size Markets, 2021 & 2027
  4.1.2 Mmunomedics Technology
  4.1.3 Immunogen Technology
  4.1.4 Seattle Genetics Technology
  4.1.5 Others
4.2 By Type - Global Antibody Drug Conjugate Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Antibody Drug Conjugate Therapeutics Revenue, 2016-2021
  4.2.2 By Type - Global Antibody Drug Conjugate Therapeutics Revenue, 2022-2027
  4.2.3 By Type - Global Antibody Drug Conjugate Therapeutics Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Antibody Drug Conjugate Therapeutics Market Size, 2021 & 2027
  5.1.2 Lymphoma
  5.1.3 Leukemia
  5.1.4 Multiple Myeloma
  5.1.5 Skin Cancer
  5.1.6 Colon Cancer
  5.1.7 Glioblastoma
  5.1.8 Pancreatic Cancer
  5.1.9 Prostate Cancer
  5.1.10 Solid Tumor
  5.1.11 Breast Cancer
5.2 By Application - Global Antibody Drug Conjugate Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Antibody Drug Conjugate Therapeutics Revenue, 2016-2021
  5.2.2 By Application - Global Antibody Drug Conjugate Therapeutics Revenue, 2022-2027
  5.2.3 By Application - Global Antibody Drug Conjugate Therapeutics Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Antibody Drug Conjugate Therapeutics Market Size, 2021 & 2027
6.2 By Region - Global Antibody Drug Conjugate Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Antibody Drug Conjugate Therapeutics Revenue, 2016-2021
  6.2.2 By Region - Global Antibody Drug Conjugate Therapeutics Revenue, 2022-2027
  6.2.3 By Region - Global Antibody Drug Conjugate Therapeutics Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Antibody Drug Conjugate Therapeutics Revenue, 2016-2027
  6.3.2 US Antibody Drug Conjugate Therapeutics Market Size, 2016-2027
  6.3.3 Canada Antibody Drug Conjugate Therapeutics Market Size, 2016-2027
  6.3.4 Mexico Antibody Drug Conjugate Therapeutics Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Antibody Drug Conjugate Therapeutics Revenue, 2016-2027
  6.4.2 Germany Antibody Drug Conjugate Therapeutics Market Size, 2016-2027
  6.4.3 France Antibody Drug Conjugate Therapeutics Market Size, 2016-2027
  6.4.4 U.K. Antibody Drug Conjugate Therapeutics Market Size, 2016-2027
  6.4.5 Italy Antibody Drug Conjugate Therapeutics Market Size, 2016-2027
  6.4.6 Russia Antibody Drug Conjugate Therapeutics Market Size, 2016-2027
  6.4.7 Nordic Countries Antibody Drug Conjugate Therapeutics Market Size, 2016-2027
  6.4.8 Benelux Antibody Drug Conjugate Therapeutics Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Antibody Drug Conjugate Therapeutics Revenue, 2016-2027
  6.5.2 China Antibody Drug Conjugate Therapeutics Market Size, 2016-2027
  6.5.3 Japan Antibody Drug Conjugate Therapeutics Market Size, 2016-2027
  6.5.4 South Korea Antibody Drug Conjugate Therapeutics Market Size, 2016-2027
  6.5.5 Southeast Asia Antibody Drug Conjugate Therapeutics Market Size, 2016-2027
  6.5.6 India Antibody Drug Conjugate Therapeutics Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Antibody Drug Conjugate Therapeutics Revenue, 2016-2027
  6.6.2 Brazil Antibody Drug Conjugate Therapeutics Market Size, 2016-2027
  6.6.3 Argentina Antibody Drug Conjugate Therapeutics Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Antibody Drug Conjugate Therapeutics Revenue, 2016-2027
  6.7.2 Turkey Antibody Drug Conjugate Therapeutics Market Size, 2016-2027
  6.7.3 Israel Antibody Drug Conjugate Therapeutics Market Size, 2016-2027
  6.7.4 Saudi Arabia Antibody Drug Conjugate Therapeutics Market Size, 2016-2027
  6.7.5 UAE Antibody Drug Conjugate Therapeutics Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Bayer AG
  7.1.1 Bayer AG Corporate Summary
  7.1.2 Bayer AG Business Overview
  7.1.3 Bayer AG Antibody Drug Conjugate Therapeutics Major Product Offerings
  7.1.4 Bayer AG Antibody Drug Conjugate Therapeutics Revenue in Global (2016-2021)
  7.1.5 Bayer AG Key News
7.2 Pfizer
  7.2.1 Pfizer Corporate Summary
  7.2.2 Pfizer Business Overview
  7.2.3 Pfizer Antibody Drug Conjugate Therapeutics Major Product Offerings
  7.2.4 Pfizer Antibody Drug Conjugate Therapeutics Revenue in Global (2016-2021)
  7.2.5 Pfizer Key News
7.3 Hoffman-Le Roche
  7.3.1 Hoffman-Le Roche Corporate Summary
  7.3.2 Hoffman-Le Roche Business Overview
  7.3.3 Hoffman-Le Roche Antibody Drug Conjugate Therapeutics Major Product Offerings
  7.3.4 Hoffman-Le Roche Antibody Drug Conjugate Therapeutics Revenue in Global (2016-2021)
  7.3.5 Hoffman-Le Roche Key News
7.4 Seattle Genetics
  7.4.1 Seattle Genetics Corporate Summary
  7.4.2 Seattle Genetics Business Overview
  7.4.3 Seattle Genetics Antibody Drug Conjugate Therapeutics Major Product Offerings
  7.4.4 Seattle Genetics Antibody Drug Conjugate Therapeutics Revenue in Global (2016-2021)
  7.4.5 Seattle Genetics Key News
7.5 ImmunoGen
  7.5.1 ImmunoGen Corporate Summary
  7.5.2 ImmunoGen Business Overview
  7.5.3 ImmunoGen Antibody Drug Conjugate Therapeutics Major Product Offerings
  7.5.4 ImmunoGen Antibody Drug Conjugate Therapeutics Revenue in Global (2016-2021)
  7.5.5 ImmunoGen Key News
7.6 Genentech
  7.6.1 Genentech Corporate Summary
  7.6.2 Genentech Business Overview
  7.6.3 Genentech Antibody Drug Conjugate Therapeutics Major Product Offerings
  7.6.4 Genentech Antibody Drug Conjugate Therapeutics Revenue in Global (2016-2021)
  7.6.5 Genentech Key News
7.7 Synthon Holding
  7.7.1 Synthon Holding Corporate Summary
  7.7.2 Synthon Holding Business Overview
  7.7.3 Synthon Holding Antibody Drug Conjugate Therapeutics Major Product Offerings
  7.4.4 Synthon Holding Antibody Drug Conjugate Therapeutics Revenue in Global (2016-2021)
  7.7.5 Synthon Holding Key News
7.8 Sanofi
  7.8.1 Sanofi Corporate Summary
  7.8.2 Sanofi Business Overview
  7.8.3 Sanofi Antibody Drug Conjugate Therapeutics Major Product Offerings
  7.8.4 Sanofi Antibody Drug Conjugate Therapeutics Revenue in Global (2016-2021)
  7.8.5 Sanofi Key News
7.9 Genmab
  7.9.1 Genmab Corporate Summary
  7.9.2 Genmab Business Overview
  7.9.3 Genmab Antibody Drug Conjugate Therapeutics Major Product Offerings
  7.9.4 Genmab Antibody Drug Conjugate Therapeutics Revenue in Global (2016-2021)
  7.9.5 Genmab Key News
7.10 Amgen
  7.10.1 Amgen Corporate Summary
  7.10.2 Amgen Business Overview
  7.10.3 Amgen Antibody Drug Conjugate Therapeutics Major Product Offerings
  7.10.4 Amgen Antibody Drug Conjugate Therapeutics Revenue in Global (2016-2021)
  7.10.5 Amgen Key News
7.11 Novartis
  7.11.1 Novartis Corporate Summary
  7.11.2 Novartis Business Overview
  7.11.3 Novartis Antibody Drug Conjugate Therapeutics Major Product Offerings
  7.11.4 Novartis Antibody Drug Conjugate Therapeutics Revenue in Global (2016-2021)
  7.11.5 Novartis Key News
7.12 Eli Lilly
  7.12.1 Eli Lilly Corporate Summary
  7.12.2 Eli Lilly Business Overview
  7.12.3 Eli Lilly Antibody Drug Conjugate Therapeutics Major Product Offerings
  7.12.4 Eli Lilly Antibody Drug Conjugate Therapeutics Revenue in Global (2016-2021)
  7.12.5 Eli Lilly Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Antibody Drug Conjugate Therapeutics Market Opportunities & Trends in Global Market
Table 2. Antibody Drug Conjugate Therapeutics Market Drivers in Global Market
Table 3. Antibody Drug Conjugate Therapeutics Market Restraints in Global Market
Table 4. Key Players of Antibody Drug Conjugate Therapeutics in Global Market
Table 5. Top Antibody Drug Conjugate Therapeutics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Antibody Drug Conjugate Therapeutics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Antibody Drug Conjugate Therapeutics Revenue Share by Companies, 2016-2021
Table 8. Global Companies Antibody Drug Conjugate Therapeutics Product Type
Table 9. List of Global Tier 1 Antibody Drug Conjugate Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antibody Drug Conjugate Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Antibody Drug Conjugate Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Antibody Drug Conjugate Therapeutics Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Antibody Drug Conjugate Therapeutics Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Antibody Drug Conjugate Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Antibody Drug Conjugate Therapeutics Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Antibody Drug Conjugate Therapeutics Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Antibody Drug Conjugate Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Antibody Drug Conjugate Therapeutics Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Antibody Drug Conjugate Therapeutics Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Antibody Drug Conjugate Therapeutics Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Antibody Drug Conjugate Therapeutics Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Antibody Drug Conjugate Therapeutics Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Antibody Drug Conjugate Therapeutics Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Antibody Drug Conjugate Therapeutics Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Antibody Drug Conjugate Therapeutics Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Antibody Drug Conjugate Therapeutics Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Antibody Drug Conjugate Therapeutics Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Antibody Drug Conjugate Therapeutics Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Antibody Drug Conjugate Therapeutics Revenue, (US$, Mn), 2022-2027
Table 30. Bayer AG Corporate Summary
Table 31. Bayer AG Antibody Drug Conjugate Therapeutics Product Offerings
Table 32. Bayer AG Antibody Drug Conjugate Therapeutics Revenue (US$, Mn), (2016-2021)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Antibody Drug Conjugate Therapeutics Product Offerings
Table 35. Pfizer Antibody Drug Conjugate Therapeutics Revenue (US$, Mn), (2016-2021)
Table 36. Hoffman-Le Roche Corporate Summary
Table 37. Hoffman-Le Roche Antibody Drug Conjugate Therapeutics Product Offerings
Table 38. Hoffman-Le Roche Antibody Drug Conjugate Therapeutics Revenue (US$, Mn), (2016-2021)
Table 39. Seattle Genetics Corporate Summary
Table 40. Seattle Genetics Antibody Drug Conjugate Therapeutics Product Offerings
Table 41. Seattle Genetics Antibody Drug Conjugate Therapeutics Revenue (US$, Mn), (2016-2021)
Table 42. ImmunoGen Corporate Summary
Table 43. ImmunoGen Antibody Drug Conjugate Therapeutics Product Offerings
Table 44. ImmunoGen Antibody Drug Conjugate Therapeutics Revenue (US$, Mn), (2016-2021)
Table 45. Genentech Corporate Summary
Table 46. Genentech Antibody Drug Conjugate Therapeutics Product Offerings
Table 47. Genentech Antibody Drug Conjugate Therapeutics Revenue (US$, Mn), (2016-2021)
Table 48. Synthon Holding Corporate Summary
Table 49. Synthon Holding Antibody Drug Conjugate Therapeutics Product Offerings
Table 50. Synthon Holding Antibody Drug Conjugate Therapeutics Revenue (US$, Mn), (2016-2021)
Table 51. Sanofi Corporate Summary
Table 52. Sanofi Antibody Drug Conjugate Therapeutics Product Offerings
Table 53. Sanofi Antibody Drug Conjugate Therapeutics Revenue (US$, Mn), (2016-2021)
Table 54. Genmab Corporate Summary
Table 55. Genmab Antibody Drug Conjugate Therapeutics Product Offerings
Table 56. Genmab Antibody Drug Conjugate Therapeutics Revenue (US$, Mn), (2016-2021)
Table 57. Amgen Corporate Summary
Table 58. Amgen Antibody Drug Conjugate Therapeutics Product Offerings
Table 59. Amgen Antibody Drug Conjugate Therapeutics Revenue (US$, Mn), (2016-2021)
Table 60. Novartis Corporate Summary
Table 61. Novartis Antibody Drug Conjugate Therapeutics Product Offerings
Table 62. Novartis Antibody Drug Conjugate Therapeutics Revenue (US$, Mn), (2016-2021)
Table 63. Eli Lilly Corporate Summary
Table 64. Eli Lilly Antibody Drug Conjugate Therapeutics Product Offerings
Table 65. Eli Lilly Antibody Drug Conjugate Therapeutics Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Antibody Drug Conjugate Therapeutics Segment by Type
Figure 2. Antibody Drug Conjugate Therapeutics Segment by Application
Figure 3. Global Antibody Drug Conjugate Therapeutics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Antibody Drug Conjugate Therapeutics Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Antibody Drug Conjugate Therapeutics Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Antibody Drug Conjugate Therapeutics Revenue in 2020
Figure 8. By Type - Global Antibody Drug Conjugate Therapeutics Revenue Market Share, 2016-2027
Figure 9. By Application - Global Antibody Drug Conjugate Therapeutics Revenue Market Share, 2016-2027
Figure 10. By Region - Global Antibody Drug Conjugate Therapeutics Revenue Market Share, 2016-2027
Figure 11. By Country - North America Antibody Drug Conjugate Therapeutics Revenue Market Share, 2016-2027
Figure 12. US Antibody Drug Conjugate Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Antibody Drug Conjugate Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Antibody Drug Conjugate Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Antibody Drug Conjugate Therapeutics Revenue Market Share, 2016-2027
Figure 16. Germany Antibody Drug Conjugate Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 17. France Antibody Drug Conjugate Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Antibody Drug Conjugate Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Antibody Drug Conjugate Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Antibody Drug Conjugate Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Antibody Drug Conjugate Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Antibody Drug Conjugate Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Antibody Drug Conjugate Therapeutics Revenue Market Share, 2016-2027
Figure 24. China Antibody Drug Conjugate Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Antibody Drug Conjugate Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Antibody Drug Conjugate Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Antibody Drug Conjugate Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 28. India Antibody Drug Conjugate Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Antibody Drug Conjugate Therapeutics Revenue Market Share, 2016-2027
Figure 30. Brazil Antibody Drug Conjugate Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Antibody Drug Conjugate Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Antibody Drug Conjugate Therapeutics Revenue Market Share, 2016-2027
Figure 33. Turkey Antibody Drug Conjugate Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Antibody Drug Conjugate Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Antibody Drug Conjugate Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Antibody Drug Conjugate Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 37. Bayer AG Antibody Drug Conjugate Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Pfizer Antibody Drug Conjugate Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Hoffman-Le Roche Antibody Drug Conjugate Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Seattle Genetics Antibody Drug Conjugate Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. ImmunoGen Antibody Drug Conjugate Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Genentech Antibody Drug Conjugate Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Synthon Holding Antibody Drug Conjugate Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Sanofi Antibody Drug Conjugate Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Genmab Antibody Drug Conjugate Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Amgen Antibody Drug Conjugate Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Novartis Antibody Drug Conjugate Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)